Apyx Medical Corporation

Ticker: APYX

Class Period Start: 05/12/2021

Class Period End: 03/11/2022

Registration Deadline: 08/05/2022

Submit Your Information

A securities class action has been filed in the USDC, M.D.FL. against Apyx Medical Corporation (APYX) on behalf of shareholders who purchased Apyx securities between May 12, 2021 through March 11, 2022.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors:

  • that a significant number of Apyx’s Advanced Energy products were used for off-label indications;
  • that such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events;
  • that, as a result, the Company was reasonably likely to incur regulatory scrutiny;
  • that, as a result of the foregoing, the Company’s financial results would be adversely impacted; and
  • that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.